SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-105524
Filing Date
2022-04-14
Accepted
2022-04-14 16:01:02
Documents
12
Period of Report
2022-05-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d343471ddef14a.htm DEF 14A 495316
2 GRAPHIC g343471dsp061a.jpg GRAPHIC 8812
3 GRAPHIC g343471dsp061b.jpg GRAPHIC 8284
4 GRAPHIC g343471dsp061c.jpg GRAPHIC 8166
5 GRAPHIC g343471dsp061e.jpg GRAPHIC 8543
6 GRAPHIC g343471dsp061f.jpg GRAPHIC 8466
7 GRAPHIC g343471dsp062a.jpg GRAPHIC 8134
8 GRAPHIC g343471dsp062b.jpg GRAPHIC 8253
9 GRAPHIC g343471g05n41.jpg GRAPHIC 25337
10 GRAPHIC g343471g15x87.jpg GRAPHIC 22711
11 GRAPHIC g343471g30p12.jpg GRAPHIC 116717
12 GRAPHIC g343471g52f73.jpg GRAPHIC 40303
  Complete submission text file 0001193125-22-105524.txt   819053
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39725 | Film No.: 22827176
SIC: 2834 Pharmaceutical Preparations